ARFIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.71993538802917E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29379951196995E-10 |
Normal-vs-Stage2 |
4.0170000000006E-05 |
Normal-vs-Stage3 |
1.87627691161651E-14 |
Normal-vs-Stage4 |
1.66333613549341E-12 |
Stage1-vs-Stage2 |
5.584000E-01 |
Stage1-vs-Stage3 |
3.809900E-04 |
Stage1-vs-Stage4 |
1.142320E-03 |
Stage2-vs-Stage3 |
2.598500E-02 |
Stage2-vs-Stage4 |
3.585700E-02 |
Stage3-vs-Stage4 |
7.787400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.07973654859006E-12 |
Normal-vs-AfricanAmerican |
3.96316313100442E-12 |
Normal-vs-Asian |
2.754300E-02 |
Caucasian-vs-AfricanAmerican |
3.061000E-01 |
Caucasian-vs-Asian |
5.670600E-01 |
AfricanAmerican-vs-Asian |
4.919800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.43995967664068E-12 |
Normal-vs-Female |
3.5225156125307E-12 |
Male-vs-Female |
5.275200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.43850528447842E-11 |
Normal-vs-Age(41-60Yrs) |
1.67132974127071E-12 |
Normal-vs-Age(61-80Yrs) |
9.60675983208148E-13 |
Normal-vs-Age(81-100Yrs) |
3.00900004912563E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.001800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.272600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.412800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.614590E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.535600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.139200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.36869999999945E-05 |
Normal-vs-Grade 2 |
9.91140503003862E-11 |
Normal-vs-Grade 3 |
1.77846626314704E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
9.297200E-01 |
Grade 1-vs-Grade 3 |
1.147760E-01 |
Grade 1-vs-Grade 4 |
2.938100E-03 |
Grade 2-vs-Grade 3 |
8.003100E-04 |
Grade 2-vs-Grade 4 |
2.38580000200272E-08 |
Grade 3-vs-Grade 4 |
3.363500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.16779960438407E-10 |
Normal-vs-ccB subtype |
3.98348021235506E-12 |
ccA subtype-vs-ccB subtype |
7.808500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63813407283442E-12 |
Normal-vs-N1 |
6.19189999999659E-05 |
N0-vs-N1 |
4.420800E-01 |
|
|